Cargando…

Management of intestinal failure in Europe. A questionnaire based study on the incidence and management

BACKGROUND: Intestinal failure is the outcome of a number of gastrointestinal diseases and characterized by significant reduction in functional gut mass. If not resolved patients often face long-term nutritional support. This study gathered information about how patients referred with intestinal fai...

Descripción completa

Detalles Bibliográficos
Autores principales: Staun, Michael, Hebuterne, Xavier, Shaffer, Jon, Haderslev, Kent V, Bozzetti, Frederico, Pertkiewicz, Marek, Micklewright, Ann, Moreno, Jose, Thul, Paul, Pironi, Loris
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1945021/
https://www.ncbi.nlm.nih.gov/pubmed/17610741
http://dx.doi.org/10.1186/1476-5918-6-7
Descripción
Sumario:BACKGROUND: Intestinal failure is the outcome of a number of gastrointestinal diseases and characterized by significant reduction in functional gut mass. If not resolved patients often face long-term nutritional support. This study gathered information about how patients referred with intestinal failure are managed in specialised European centres. METHODS: A questionnaire was circulated in 7 European countries via representatives of the ESPEN-HAN working group to seek information about experience in treating patients with intestinal failure. We asked about clinical outcome, information about structure and organisation of the department, referral criteria, treatment procedures and guidelines. RESULTS: 17 centres in 6 European countries completed the questionnaire: UK, n = 6, France, n = 4, Spain, n = 3, Denmark, n = 2, Italy, n = 1, Poland, n = 1. The experience of the centres in treating patients was in the range 12–30 years. The total number of patients on HPN in all centres was 590. The number of patients referred to centres with intestinal failure during the period January to December 2000 was n = 882: UK, n = 375 (range 2–175), France, n = 308 (range 24–182), Italy and Spain, n = 43 (range 9–52), Denmark n = 51 (range 14–37), the centre in Poland included 53 patients. Comparing all centres the following distribution among patients (median % (range%)) with regard to the endpoints were reported: Oral nutrition 32% (23–50%), enteral/tube feeding 11% (4–23%), HPN 36% (15–57%), lost to follow up 10% (0–35%), dead 9% (5–18%). No patients had an intestinal transplant. CONCLUSION: The study provides information about how patients with intestinal failure are managed across Europe and the data indicates that treatment practice varies between countries.